Literature DB >> 27136062

Therapeutic Potential of Natural Product-Based Oral Nanomedicines for Stroke Prevention.

Tatsushi Mutoh1,2, Tomoko Mutoh1, Yasuyuki Taki1, Tatsuya Ishikawa2.   

Abstract

Cerebral stroke is the leading cause of death and permanent disability in elderly persons. The impaired glucose and oxygen transport to the brain during ischemia causes bioenergetic failure, leading to oxidative stress, inflammation, blood-brain barrier dysfunction, and eventually cell death. However, the development of effective therapies against stroke has been hampered by insufficient oral absorption of pharmaceuticals and subsequent delivery to the brain. Nanotechnology has emerged as a new method of treating cerebral diseases, with the potential to fundamentally change currently available therapeutic approaches using compounds with low bioavailability. This perspective review provides an overview of the therapeutic potential of oral nanomedicines for stroke, focusing on novel natural product-loaded delivery system with potent antioxidant and anti-inflammatory effects.

Entities:  

Keywords:  antioxidant activity; bioflavonoids; cerebral ischemia; dietary herbal supplement; nanomedicine; natural product; neuroprotection; stroke

Mesh:

Substances:

Year:  2016        PMID: 27136062      PMCID: PMC4904166          DOI: 10.1089/jmf.2015.3644

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  47 in total

Review 1.  Drug delivery to the central nervous system: a review.

Authors:  Ambikanandan Misra; S Ganesh; Aliasgar Shahiwala; Shrenik P Shah
Journal:  J Pharm Pharm Sci       Date:  2003 May-Aug       Impact factor: 2.327

2.  Acute kidney injury and edaravone in acute ischemic stroke: the Fukuoka Stroke Registry.

Authors:  Masahiro Kamouchi; Hironori Sakai; Yutaka Kiyohara; Kazuo Minematsu; Kunihiko Hayashi; Takanari Kitazono
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-06-22       Impact factor: 2.136

Review 3.  Duration of neuroprotective treatment for ischemic stroke.

Authors:  A G Dyker; K R Lees
Journal:  Stroke       Date:  1998-02       Impact factor: 7.914

Review 4.  Reactive oxygen radicals in signaling and damage in the ischemic brain.

Authors:  P H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2001-01       Impact factor: 6.200

5.  Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats.

Authors:  Vandita Kakkar; Sravan Kumar Muppu; Kanwaljit Chopra; Indu Pal Kaur
Journal:  Eur J Pharm Biopharm       Date:  2013-02-27       Impact factor: 5.571

6.  Solid lipid nanoparticles: a modern formulation approach in drug delivery system.

Authors:  S Mukherjee; S Ray; R S Thakur
Journal:  Indian J Pharm Sci       Date:  2009-07       Impact factor: 0.975

7.  Novel multiple agents loaded PLGA nanoparticles for brain delivery via inner ear administration: in vitro and in vivo evaluation.

Authors:  Xiao Zhang; Gang Chen; Lu Wen; Fan Yang; A-li Shao; Xia Li; Wei Long; Lei Mu
Journal:  Eur J Pharm Sci       Date:  2013-01-23       Impact factor: 4.384

8.  Free radical scavenger, edaravone, reduces the lesion size of lacunar infarction in human brain ischemic stroke.

Authors:  Taizen Nakase; Shotaroh Yoshioka; Akifumi Suzuki
Journal:  BMC Neurol       Date:  2011-03-30       Impact factor: 2.474

Review 9.  Natural product-based nanomedicine: recent advances and issues.

Authors:  Rebekah Watkins; Ling Wu; Chenming Zhang; Richey M Davis; Bin Xu
Journal:  Int J Nanomedicine       Date:  2015-09-28

10.  Systems pharmacology dissection of multi-scale mechanisms of action for herbal medicines in stroke treatment and prevention.

Authors:  Jingxiao Zhang; Yan Li; Xuetong Chen; Yanqiu Pan; Shuwei Zhang; Yonghua Wang
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

View more
  5 in total

1.  Transferrin-Enabled Blood-Brain Barrier Crossing Manganese-Based Nanozyme for Rebalancing the Reactive Oxygen Species Level in Ischemic Stroke.

Authors:  Qianqian Zhao; Wenxian Du; Lingling Zhou; Jianrong Wu; Xiaoxing Zhang; Xiaoer Wei; Sijia Wang; Yu Huang; Yuehua Li
Journal:  Pharmaceutics       Date:  2022-05-25       Impact factor: 6.525

Review 2.  Oral and Intra-nasal Administration of Nanoparticles in the Cerebral Ischemia Treatment in Animal Experiments: Considering its Advantages and Disadvantages.

Authors:  Firoozeh Alavian; Nasrin Shams
Journal:  Curr Clin Pharmacol       Date:  2020

Review 3.  Nanoparticles in Combating Neuronal Dysregulated Signaling Pathways: Recent Approaches to the Nanoformulations of Phytochemicals and Synthetic Drugs Against Neurodegenerative Diseases.

Authors:  Sadaf Abdian; Seyede Nazanin Zarneshan; Sajad Fakhri; Seyed Zachariah Moradi; Mohammad Hosein Farzaei; Mohammad Abdollahi
Journal:  Int J Nanomedicine       Date:  2022-01-22

Review 4.  Natural Compounds for SIRT1-Mediated Oxidative Stress and Neuroinflammation in Stroke: A Potential Therapeutic Target in the Future.

Authors:  Chaoyou Fang; Houshi Xu; Ling Yuan; Zhengyang Zhu; Xiaoyu Wang; Yibo Liu; Anke Zhang; Anwen Shao; Meiqing Lou
Journal:  Oxid Med Cell Longev       Date:  2022-09-05       Impact factor: 7.310

Review 5.  Alzheimer's disease: natural products as inhibitors of neuroinflammation.

Authors:  Olumayokun A Olajide; Satyajit D Sarker
Journal:  Inflammopharmacology       Date:  2020-09-15       Impact factor: 4.473

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.